Optogenetic Inhibitor of the Transcription Factor CREB
Ahmed M Ali1, Jakeb M Reis2, Yan Xia3
1Department of Chemistry, University of Toronto, 80 St. George Street, Toronto, ON M5S 3H6, Canada; Department of Medicinal Chemistry, Faculty of Pharmacy, Assiut University, Assiut 71515, Egypt.
Abstract:
Current approaches for optogenetic control of transcription do not mimic the activity of endogenous transcription factors, which act at numerous sites in the genome in a complex interplay with other factors. Optogenetic control of dominant negative versions of endogenous transcription factors provides a mechanism for mimicking the natural regulation of gene expression. Here we describe opto-DN-CREB, a blue-light-controlled inhibitor of the transcription factor CREB created by fusing the dominant negative inhibitor A-CREB to photoactive yellow protein (PYP). A light-driven conformational change in PYP prevents coiled-coil formation between A-CREB and CREB, thereby activating CREB. Optogenetic control of CREB function was characterized in vitro, in HEK293T cells, and in neurons where blue light enabled control of expression of the CREB targets NR4A2 and c-Fos. Dominant negative inhibitors exist for numerous transcription factors; linking these to optogenetic domains offers a general approach for spatiotemporal control of native transcriptional events.
Insights
This study introduces opto-DN-CREB, a novel optogenetic tool for controlling gene expression. Blue light activates CREB (cAMP response element-binding protein) by modulating a dominant-negative inhibitor, enabling precise regulation of transcription.
Area of Science:
- Molecular Biology
- Neuroscience
- Optogenetics
Background:
- Current optogenetic transcription control lacks mimicry of endogenous factors.
- Endogenous transcription factors exhibit complex, multi-site genomic interactions.
- Dominant-negative inhibitors offer a pathway to mimic natural gene regulation.
Purpose of the Study:
- To develop a novel optogenetic system for precise transcription factor control.
- To create a blue-light-inducible dominant-negative inhibitor for CREB.
- To demonstrate spatiotemporal regulation of CREB activity and its downstream targets.
Main Methods:
- Fusion of A-CREB (dominant-negative CREB inhibitor) with photoactive yellow protein (PYP).
- Utilizing PYP's light-induced conformational change to regulate A-CREB/CREB interaction.
- In vitro, cell-based (HEK293T), and neuronal experiments to validate functionality.
Main Results:
- Opto-DN-CREB demonstrated blue-light-dependent inhibition of CREB activity.
- Activation of CREB was achieved by preventing A-CREB/CREB coiled-coil formation.
- Controlled expression of CREB target genes (NR4A2, c-Fos) in neurons via blue light.
Conclusions:
- Opto-DN-CREB provides a generalizable method for optogenetic control of transcription factors.
- This approach mimics natural gene regulation by controlling dominant-negative inhibitors.
- Offers a versatile platform for spatiotemporal manipulation of native transcriptional events.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Inhibition of Cdk Activity
Reporter Genes
RNA Polymerase II Accessory Proteins
Prokaryotic Transcriptional Activators and Repressors
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...


